FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
The FDA has approved Recarbrio (a combination of imipenem-cilastatin and relebactam) to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 4, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Leave Clothes Out In The Sun? Do Flu Shots Protect? Dr. Mallika Marshall Answers Your Coronavirus Questions
BOSTON (CBS) — As Massachusetts continues to fight the coronavirus pandemic, the public has plenty of questions. Dr. Mallika Marshall answered some of those sent to her email (drmallika@cbs.com) and Facebook and Twitter accounts.
I want know why all of these surgeries have been canceled. Mine was canceled and I’m in a lot of pain. – Trish, Canada
Not just in Canada. Elective and nonemergency surgeries have been postponed throughout the U.S. in an effort to protect patients, healthcare workers, and free up hospital beds. Hospitals are anxious to resume elective surgeries, but the ability will be based on the ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 15, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news
COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital [NG173], NICE (published 1st May 2020)
The guideline emphasises the importance of careful antibiotic prescribing and prompt review after testing. It is important to note that during the COVID ‑19 pandemic, most cases of pneumonia have been viral and therefore antibiotics are ineffective unless there is a bacterial co-infection. For patients with suspected or confirmed bacterial pneumonia, a broad-spectrum antibiotic should be given as soon as possible unless there is significant confid ence about the absence of bacterial co-infection. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 1, 2020 Category: Consumer Health News Source Type: news
How Safe Is The Meat Supply Chain? Dr. Mallika Marshall Answers Your Coronavirus Questions
BOSTON (CBS) – As the number of coronavirus cases continues to grow, we are receiving a number of questions from the public. Dr. Mallika Marshall answered some of the questions sent to WBZ-TV’s Facebook, Instagram and Twitter accounts.
What does ‘non-conclusive’ mean regarding COVID-19 test results? – Karen, Facebook
An inconclusive test means it can’t confirm whether a patient is positive or negative for the coronavirus. The current test looks for the presence of two genes associated with the virus. If both genes are found, the test is positive. If neither is found, it’s negative. And if only one gene i...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 29, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news
As virus advances, doctors rethink rush to ventilators
The picture is partial and evolving, but it suggests people with COVID-19 who have been intubated have had, at least in the early stages of the pandemic, a higher rate of death than other patients on ventilators who have conditions such as bacterial pneumonia or collapsed lungs. (Source: The Economic Times)
Source: The Economic Times - April 26, 2020 Category: Consumer Health News Source Type: news
COVID-19 rapid guideline: managing suspected or confirmed pneumonia in adults in the community [NG165], NICE (updated 23rd April 2020)
Latest update: 23 April 2020 The recommendations on antibiotic treatment for bacterial pneumonia in the community during the COVID-19 pandemic were clarified. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 24, 2020 Category: Consumer Health News Source Type: news
Why Some Doctors Are Now Moving Away From Ventilator Treatments for Coronavirus Patients
(NEW YORK) — As health officials around the world push to get more ventilators to treat coronavirus patients, some doctors are moving away from using the breathing machines when they can. The reason: Some hospitals have reported unusually high death rates for coronavirus patients on ventilators, and some doctors worry that the machines could be harming certain patients.
Read more: Front Line Workers Tell Their Own Stories in the New Issue of TIME
The evolving treatments highlight the fact that doctors are still learning the best way to manage a virus that emerged only months ago. They are relying on anecdotal, real-t...
Source: TIME: Health - April 9, 2020 Category: Consumer Health News Authors: Mike Stobbe / AP Tags: Uncategorized COVID-19 News Desk wire Source Type: news
President Trump Called Hydroxychloroquine a ‘Game Changer,’ But Experts Warn Against Self-Medicating With the Drug. Here’s What You Need to Know
After President Trump, late last week, expressed great confidence in the promise of a new COVID-19 therapy that combines two existing prescription medications, supplies of these two drugs rapidly began disappearing from pharmacy shelves. The U.S. Food and Drug Administration allowed an Indian company previously restricted from importing drug products into the US to now start manufacturing one of the drugs. And U.S. plants began gearing up to produce enough to meet the surge in demand.
But in those few days, a few people who began self medicating with the drugs in an effort to prevent COVID-19 have died, and others have bee...
Source: TIME: Health - March 24, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Removing body clock gene protects mice against pneumonia
(University of Oxford) This is the first time a clock gene has been found to affect resistance to bacterial pneumonia, a fatal disease responsible for 5% of all deaths in the UK each year. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 6, 2020 Category: International Medicine & Public Health Source Type: news
Skin and mucous membrane lesions as complication of pneumonia
(University of Zurich) Painful inflammatory lesions of the skin and mucous membranes may occur in children who develop bacterial pneumonia. A research group at the University Children's Hospital Zurich has recently developed a new diagnostic blood test, which reliably diagnoses bacteria as the causative pathogen at an early stage, allowing more specific treatment and prediction about prognosis. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 19, 2019 Category: Infectious Diseases Source Type: news
Up to 43% of Antibiotic Prescriptions in the U.S. Are Unnecessary or Improperly Written, Analysis Finds
The World Health Organization earlier this year called antimicrobial resistance—pathogens’ ability to evade medical interventions—one of the 10 largest threats to global health. In the U.S. alone, according to a recent Centers for Disease Control and Prevention (CDC) report, 35,000 people die each year due to antibiotic-resistant infections.
A new study published in the BMJ points to one major propagator of the problem: doctors are prescribing antibiotics when they shouldn’t. In fact, up to 43% of U.S. antibiotic prescriptions may be “inappropriate,” according to the research.
Antibioti...
Source: TIME: Health - December 11, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Research Source Type: news
FDA Approves New Indication for Delafloxacin for CABP FDA Approves New Indication for Delafloxacin for CABP
Following approval in 2017 for bacteria skin infections, the fluoroquinolone antibiotic is now indicated for adults with community-acquired bacterial pneumonia.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 25, 2019 Category: Drugs & Pharmacology Tags: Infectious Diseases News Alert Source Type: news
FDA Approves Baxdela (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)
MORRISTOWN, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 24, 2019 Category: Drugs & Pharmacology Source Type: news
New Antibiotic Approved for Community-Acquired Bacterial Pneumonia
Title: New Antibiotic Approved for Community-Acquired Bacterial PneumoniaCategory: Health NewsCreated: 8/19/2019 12:00:00 AMLast Editorial Review: 8/20/2019 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - August 20, 2019 Category: Respiratory Medicine Source Type: news
FDA approves King of Prussia company's pneumonia drug
The Food and Drug Administration approved Nabriva Therapeutics' drug application for its antibiotic Xenleta.
Xenleta treats community-acquired bacterial pneumonia (CABP), a leading cause of infection-related deaths in the United States.
Nabriva's stock was up 20% at $2.67 per share in after-hours trading Monday.
According to the company, about 5 million cases of pneumonia are reported in the United Sta tes each year, and pneumonia is the fifth-leading cause of hospitalizations.
Nabriva said Xenleta… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 20, 2019 Category: Biotechnology Authors: John George Source Type: news
